Stock Events

Stock Events

Restart Life Sciences 

€0.046500
69
+€0.00+12.05% 07:06 Today

Statistics

Day High
0.0465
Day Low
0.0465
52W High
0.0735
52W Low
0.0385
Volume
-
Avg. Volume
-
Mkt Cap
2.9M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-879,256.29Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap81.62M
Corbus Pharmaceuticals targets endocannabinoid system therapies, overlapping with Nova Mentis' research interests.
Anavex Life Sciences
AVXL
Mkt Cap110.31M
Anavex Life Sciences Corp. focuses on developing therapies for neurodegenerative and neurological diseases, directly competing with Nova Mentis.
Acadia Pharmaceuticals
ACAD
Mkt Cap3.55B
ACADIA Pharmaceuticals specializes in CNS disorders, potentially competing with Nova Mentis' focus areas.
Alkermes
ALKS
Mkt Cap7B
Alkermes plc works on central nervous system (CNS) disorders, including treatments that could compete with Nova Mentis' products.
Incyte
INCY
Mkt Cap24.54B
Incyte Corporation has a broad portfolio that includes treatments for neurological conditions, posing competition to Nova Mentis.
Palatin Technologies
PTN
Mkt Cap8.9M
Palatin Technologies is involved in developing therapeutic compounds that could compete with Nova Mentis' focus on mental health and neurological disorders.

About

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company in Canada. It engages in research and development of psilocybin; and fund food-related research initiative in support of its expanding portfolio of consumer health and wellness products. The company has collaboration with the University of Manitoba's Richardson Centre for food technology and research (RCFTR) to support a series of food-related scientific studies, including the development across various product lines, including BrainQ, BrainBalls, and Holy Crap. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada.
Show More
CEO
Steve Loutskou
Employees
3
Country
Canada
ISIN
CA76134J2065
WKN
000A410C5

Listings

F
DE
HN30.F
STU
DE
HN30.STU
CN
CA
HEAL.CN
OTC Link
US
NMLSF

0 Comments

Share your thoughts

FAQs

What is Restart Life Sciences stock price today?▼
The current price of HN30.F is €0.05 EUR — it has increased by +12.05% in the past 24 hours. Watch Restart Life Sciences stock price performance more closely on the chart.
What is Restart Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Restart Life Sciences stocks are traded under the ticker HN30.F.
Is Restart Life Sciences stock price growing?▼
HN30.F stock has risen by +8.14% compared to the previous week, the month change is a +10.71% rise, over the last year Restart Life Sciences has showed a -12.26% decrease.
What is Restart Life Sciences market cap?▼
Today Restart Life Sciences has the market capitalization of 2.9M
What is Restart Life Sciences revenue for the last year?▼
Restart Life Sciences revenue for the last year amounts to 0 EUR.
What is Restart Life Sciences net income for the last year?▼
HN30.F net income for the last year is -879,256.29 EUR.
How many employees does Restart Life Sciences have?▼
As of November 2, 2026, the company has 3 employees.
In which sector is Restart Life Sciences located?▼
Restart Life Sciences operates in the Health & Wellness sector.
When did Restart Life Sciences complete a stock split?▼
The last stock split for Restart Life Sciences was on January 24, 2025 with a ratio of 1:2.
Where is Restart Life Sciences headquartered?▼
Restart Life Sciences is headquartered in Vancouver, Canada.